Elanco said it will report third-quarter 2026 financial results on November 6 and hold an earnings call at 8 a.m. Eastern. The company plans to provide a public webcast and a replay through its investor website.
Elanco announced that its chief executive, chief financial officer and U.S. Pet Health leader would participate in a September 15 fireside chat at the Morgan Stanley healthcare conference. The company said a limited-time replay would follow on its investor website.
Zimmer Biomet announced promotions for Gary Campbell, Brian Hatcher and Bradley Kessler as it reorganizes commercial leadership. The company said Campbell and Hatcher take their new roles October 1 and reiterated its 2026 financial outlook.
Zimmer Biomet announced a quarterly cash dividend of $0.24 per share. The company said payment is expected on or about October 30, 2026, for shareholders of record at the close of September 30.
Catalent announced a $4.1 billion equivalent term loan and a $600 million revolving credit facility. The company expects about $100 million in annual interest savings. This is a corporate financing announcement, not a Bloomington-specific investment.
Evansville-based Escalade announced its acquisition of ASL Solutions assets, including insulated pet houses and related products. The company said the Illinois operation adds rotational-molding capabilities and will join its US Weight Group portfolio.
Duke Energy and its foundation announced more than $50,000 for local organizations assisting communities with food, cleanup and other storm recovery needs.
Elements Financial announced a September 9 upgrade combining its online and mobile banking tools. The credit union also described a September upgrade for business banking and a temporary view-only period during the transition.
Arcwood Environmental announced its acquisition of Environmental Management Services, Inc., a 42-person Maryland company. The Indianapolis-based issuer said the purchase expands its Mid-Atlantic hazardous-waste and emergency-response capabilities.
Allison released second-quarter results incorporating its acquired off-highway business and reported record quarterly sales in its transmission segment.
In a corporate announcement, Catalent and Taysha said they expanded their partnership for investigational Rett syndrome therapy TSHA-102, subject to potential FDA approval. The planned manufacturing is in Harmans, Maryland; this release does not announce a Bloomington project.
Catalent announced a corporate agreement to support late-stage development and potential commercial supply of Nanoscope’s investigational MCO-010 gene therapy. The company described packaging validation and distribution support; it did not announce a Bloomington project.